Karsenty garners inaugural Herbert A. Fleisch Medal
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis and the International Osteoporosis Foundation recently announced that Gerard Karsenty of the Columbia University Medical Center has been awarded the first Herbert A. Fleisch ESCEO-IOF Medal. Herbert Fleisch was a renowned researcher whose groundbreaking work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment.
The newly created award, valued at 20,000 euros, recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science.
Karsenty is professor and chair in the department of genetics and development at the Columbia University Medical Center. He is known for his many fundamental contributions to understanding skeletal development and skeletal physiology. Karsenty’s laboratory has been instrumental in identifying Runx2 as the master gene of osteoblast differentiation and in deciphering the genetic cascade of osteoblast differentiation. He also has contributed to the molecular elucidation of bone mineralization and has made significant advances in the study of bone physiology. Lastly, Karsenty’s lab has shown that gut-derived serotonin is a powerful inhibitor of bone formation.
Schachter and Silbert receive award for lifetime achievement in glycobiology
The Society for Glycobiology recently awarded the 2010 Rosalind Kornfeld Award Lifetime Achievement in Glycobiology to Harry Schachter and Jeremiah Silbert.
The Kornfeld award was established in 2008 to honor Kornfeld’s distinguished scientific career and service to the Society for Glycobiology. The award is given to scientists who have, over their professional lifetimes, made significant contributions to glycobiology.
Schachter is professor emeritus of biochemistry at the University of Toronto and senior scientist emeritus at the Research Institute at the Hospital for Sick Children in Toronto. He has made many seminal contributions to glycobiology and the biochemistry of glycan synthesis.
Silbert is a professor of medicine at Harvard Medical School and Brigham and Women’s Hospital and senior medical investigator emeritus at the Veterans Affairs Medical Center. He has pioneered studies on glycosaminoglycan biosynthesis, structure, function, degradation, localization, and description in cells and tissues.